CSIMarket Company Name, Ticker, Suppliers, else..


Amylyx Pharmaceuticals Inc   (NASDAQ: AMLX)
Other Ticker:  
 

Amylyx Pharmaceuticals Inc

AMLX's Fundamental analysis



Amylyx Pharmaceuticals Inc 's sales fell in the first quarter of 2025 from the same quarter a year ago. Ranking at No. 1327

Major Pharmaceutical Preparations industry recorded growth of revenues by 4.44 %

Amylyx Pharmaceuticals Inc net loss decreased from $-119 millions, to $-36 millions in first quarter of 2025,

• More on AMLX's Growth


Amylyx Pharmaceuticals Inc
realized a net loss in trailing twelve months.

Amylyx Pharmaceuticals Inc realized cash reduction of $ -1.28 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.48.


• More on AMLX's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 2.35

Amylyx Pharmaceuticals Inc
realized net loss in trailing twelve months.

Amylyx Pharmaceuticals Inc realized cash outflow of $ -1.28per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.48.

Amylyx Pharmaceuticals Inc Price to Book Ratio is at 3.08 lower than Industry Avg. of 35.08. and higher than S&P 500 Avg. of 0.01

• More on AMLX's Valuation

•  Market Capitalization (Millions $) 620
•  Shares Outstanding (Millions) 86
•  Employees 113
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -219
•  Cash Flow (TTM) (Millions $) -110
•  Capital Exp. (TTM) (Millions $) -36
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ -
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 2.35

•  Market Capitalization (Millions $) 620
•  Shares Outstanding (Millions) 86
•  Employees 113
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -219
•  Cash Flow (TTM) (Millions $) -110
•  Capital Exp. (TTM) (Millions $) -36





  Ratio
•   Capital Ratio (MRQ) 12.05
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.09
•  Asset Turnover Ratio (TTM) -
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com